A previous small clinical study including 11 SET-NUP214 positive adult T-ALL patients described that SET-NUP214 fusion is associated with both corticosteroid and chemotherapy resistance to early/initial antileukemic treatment, but despite this resistance, the majority of patients later achieve completed remission [133]. Here, NUP214 is linked to acute lymphoblastic leukemia.